Biohacker CRISPRs himself in attempt to get bigger muscles
By GMWatch,
GMWatch
| 12. 11. 2017
A CBS News story reports an attempt by the biohacker Josiah Zayner to genetically modify himself to have bigger muscles, using the CRISPR genome-editing tool.
It seems that Zayner tried to alter his DNA by injecting his forearm with a piece of DNA called a plasmid, containing the gene that codes for the Cas9 genome-editing protein and its guide RNA targeted to the myostatin gene. The myostatin protein encoded by this gene checks the growth of muscles so they don’t become out-of-proportion huge. Zayner’s aim is to disrupt the myostatin gene that blocks muscle growth so that his muscles get larger.
Zayner carried out this process using a CRISPR kit that is available to buy online. Presumably it’s the same one that his own company sells and that he hopes to profit from.
Zayner described to CBS his view of the future possibilities with CRISPR: "Do I wanna be big and muscly? Do I wanna – you know, my muscles have, like, high endurance? Do I want to have dark colour skin or light colour skin or whatever you want...
Related Articles
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...